However, this difference did not reach statistical significance, which could be explained by the heterogeneity of TB disease within the patient groups.
← all excerpts
IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection.
1
—
—